Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Inoue

Showing results (571-580 of 796) with videos related to

Pageof 80
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 22, 2015
Can rotational thromboelastometry predict septic disseminated intravascular coagulation?Hiroyuki Koami, Yuichiro Sakamoto, Miho Ohta, et al.
International Journal of Environmental Research and Public Health|June 30, 2018
Human Exposure to Ferret Badger Rabies in TaiwanTai-Hwa Shih, Jeng-Tung Chiang, Hung-Yi Wu, et al.
Hormones & Cancer|April 6, 2012
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patientsNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.
Biochemical and Biophysical Research Communications|June 9, 2004
14-3-3sigma is down-regulated in human prostate cancerTomohiko Urano, Satoru Takahashi, Takashi Suzuki, et al.
International Journal of Cancer|November 26, 2008
EBAG9 is a tumor-promoting and prognostic factor for bladder cancerJinpei Kumagai, Tomohiko Urano, Tetsuo Ogushi, et al.
Journal of Virological Methods|April 8, 2019
Establishment of an immunofluorescence assay to detect IgM antibodies to Nipah virus using HeLa cells expressing recombinant nucleoproteinYoshihiro Kaku, Eun-Sil Park, Akira Noguchi, et al.
The Prostate|April 25, 2007
Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancerJinpei Kumagai, Tetsuya Fujimura, Satoru Takahashi, et al.
Hormones & Cancer|September 9, 2011
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancerTakashi Shigekawa, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.
Scientific Reports|August 11, 2015
miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1AKazuhiro Ikeda, Kuniko Horie-Inoue, Toshihide Ueno, et al.
Cancer Science|May 22, 2020
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancerYuichi Mitobe, Kazuhiro Ikeda, Wataru Sato, et al.
Pageof 80

Showing results (571-580 of 796) with videos related to

Sort By:
Pageof 80
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 22, 2015
Can rotational thromboelastometry predict septic disseminated intravascular coagulation?Hiroyuki Koami, Yuichiro Sakamoto, Miho Ohta, et al.
International Journal of Environmental Research and Public Health|June 30, 2018
Human Exposure to Ferret Badger Rabies in TaiwanTai-Hwa Shih, Jeng-Tung Chiang, Hung-Yi Wu, et al.
Hormones & Cancer|April 6, 2012
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patientsNobuhiro Ijichi, Takashi Shigekawa, Kazuhiro Ikeda, et al.
Biochemical and Biophysical Research Communications|June 9, 2004
14-3-3sigma is down-regulated in human prostate cancerTomohiko Urano, Satoru Takahashi, Takashi Suzuki, et al.
International Journal of Cancer|November 26, 2008
EBAG9 is a tumor-promoting and prognostic factor for bladder cancerJinpei Kumagai, Tomohiko Urano, Tetsuo Ogushi, et al.
Journal of Virological Methods|April 8, 2019
Establishment of an immunofluorescence assay to detect IgM antibodies to Nipah virus using HeLa cells expressing recombinant nucleoproteinYoshihiro Kaku, Eun-Sil Park, Akira Noguchi, et al.
The Prostate|April 25, 2007
Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancerJinpei Kumagai, Tetsuya Fujimura, Satoru Takahashi, et al.
Hormones & Cancer|September 9, 2011
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancerTakashi Shigekawa, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.
Scientific Reports|August 11, 2015
miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1AKazuhiro Ikeda, Kuniko Horie-Inoue, Toshihide Ueno, et al.
Cancer Science|May 22, 2020
Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancerYuichi Mitobe, Kazuhiro Ikeda, Wataru Sato, et al.
Pageof 80